• Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Walvax Biotechnology Co Ltd

+ Add to Watchlist

300142:CH

42.800 CNY 0.050 0.12%

As of 03:00:27 ET on 09/10/2014.

Trading has been halted for 300142:CH

Snapshot for Walvax Biotechnology Co Ltd (300142)

Open: 42.740 Day's Range: 42.400 - 43.050 Volume: 964,669
Previous Close: 42.750 52wk Range: 25.923 - 43.946 1-Yr Rtn: -

Stock Chart for 300142

No chart data available.
  • 300142:CH 42.800
  • 1D
  • 1M
  • 1Y
42.750
Interactive 300142 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 300142

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 180.5907
Relative P/E vs. SZ399006 -
Earnings Per Share (CNY) (ttm) -0.3832
Est. EPS (CNY) (12/2014) 0.2370
Est. PEG Ratio -
Market Cap (M CNY) 10,015.20
Shares Outstanding (M) 234.00
30 Day Average Volume 1,190,496
Price/Book (mrq) 3.7486
Price/Sale (ttm) 13.5244
Dividend Indicated Gross Yield 0.09%
Cash Dividend (CNY) 0.0385
Dividend Ex-Date 05/30/2014
5 Year Dividend Growth -
Next Earnings Announcement 10/27/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 300142

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 300142

Walvax Biotechnology Company Limited develops, manufactures and sells bio-pharmaceutical vaccination products. The Company's products include haemophilus influenzae type b conjugate vaccine and meningococcal group A,C bivalent polysaccharide conjugate vaccine.

Li YunchunChairman/PresidentChen ErjiaVice Chairman
Huang ZhenVice PresidentYang ZhongdongVice President
More Company Profile & Key Executives for 300142

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil